Martin Schuler

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

Martin Schuler

Jan 8, 2025, 14:32 | Blog

Aakash Desai: Autogene cevumeran redefining personalized cancer treatment

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn: "mRNA-based Immunotherapy…

Dec 29, 2024, 11:07 | Science

The highest cited original research publications in Pancreatic Cancer from 2020 to 2024 by Anirban Maitra

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center,…

Jun 29, 2024, 14:04 | Insight

Piotr Wysocki: Combination of nivolumab and relatlimab in neoadjuvant setting in resectable NSCLC

Piotr Wysocki recently posted on LinkedIn: "Martin Schuler et al. published results of their phase 2…

All: 3 Posts: 1 - 100

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

'

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023